# A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children

> **NCT00760825** · PHASE4 · COMPLETED · sponsor: **International Vaccine Institute** · enrollment: 200 (actual)

## Conditions studied

- Vibrio Cholerae

## Interventions

- **BIOLOGICAL:** killed bivalent (O1 and O139)whole cell oral cholera vaccine

## Key facts

- **NCT ID:** NCT00760825
- **Lead sponsor:** International Vaccine Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-04
- **Final completion:** 2013-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-06-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760825, "A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00760825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*